BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Cervical cancer AND SET, I2PP2A, 6418, ENSG00000119335, TAF-IBETA, PHAPII, IGAAD, 2PP2A AND Treatment
476 results:

  • 1. A Comparative Study of Clinical Outcomes in Locally Advanced cervical cancer: External Beam Radiotherapy (EBRT) and Sequential High Dose Rate Intracavitary Brachytherapy (HDRICBT) with or without Concurrent Cisplatin on the Day of ICBT Insertion - A Tertiary Care Center Randomized Controlled Trial in India.
    Alim S; Siddiqui SA; Akram M; Hakim S; Khan MA
    Asian Pac J Cancer Prev; 2024 Apr; 25(4):1333-1338. PubMed ID: 38679994
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. A Comparative Study of Deep Learning Dose Prediction Models for cervical cancer Volumetric Modulated Arc Therapy.
    Wu Z; Liu M; Pang Y; Deng L; Yang Y; Wu Y
    Technol Cancer Res Treat; 2024; 23():15330338241242654. PubMed ID: 38584413
    [No Abstract]    [Full Text] [Related]  

  • 3. Health related quality of life and its predictive factors on cervical cancer patients in two teaching hospitals, Addis Ababa, Ethiopia.
    Seyfu DT; Abebe SN; Haile S; Ayana BA
    BMC Womens Health; 2024 Apr; 24(1):209. PubMed ID: 38566073
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. STING agonist inflames the cervical cancer immune microenvironment and overcomes anti-PD-1 therapy resistance.
    Li T; Zhang W; Niu M; Wu Y; Deng X; Zhou J
    Front Immunol; 2024; 15():1342647. PubMed ID: 38550593
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Comparative effectiveness of implementation strategies for Accelerating cervical cancer Elimination through the integration of Screen-and-treat Services (ACCESS study): protocol for a cluster randomized hybrid type III trial in Nigeria.
    Olakunde BO; Itanyi IU; Olawepo JO; Liu L; Bembir C; Idemili-Aronu N; Lasebikan NN; Onyeka TC; Dim CC; Chigbu CO; Ezeanolue EE; Aarons GA
    Implement Sci; 2024 Mar; 19(1):25. PubMed ID: 38468266
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Socioeconomic disparities and regional environment are associated with cervical lymph node metastases in children and adolescents with differentiated thyroid cancer: developing a web-based predictive model.
    Mao Y; Wang J; Luo Y; Lin W; Yao J; Wen J; Chen G
    Front Endocrinol (Lausanne); 2024; 15():1128711. PubMed ID: 38449854
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Elevated INHBA Promotes Tumor Progression of cervical cancer.
    Wu Z; Chen J; Yang L; Sun K; Jiang Q; Dong F; Lu W; Chen R; Chen Y
    Technol Cancer Res Treat; 2024; 23():15330338241234798. PubMed ID: 38419562
    [No Abstract]    [Full Text] [Related]  

  • 8. Prediction of cervical lymph node metastasis in differentiated thyroid cancer based on radiomics models.
    Mu J; Cao Y; Zhong X; Diao W; Jia Z
    Br J Radiol; 2024 Feb; 97(1155):526-534. PubMed ID: 38366237
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Clinical analysis of a new multifunctional instrument set for gasless endoscopic thyroidectomy with two different approaches.
    Hu B; Chen Y; Jin Y; Liu X; Chen Y; Tang J; Liu Y; Zhang Z; Wang N; Bai R; Jin G
    Surg Endosc; 2024 Apr; 38(4):1958-1968. PubMed ID: 38347218
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Exploring a novel seven-gene marker and mitochondrial gene TMEM38A for predicting cervical cancer radiotherapy sensitivity using machine learning algorithms.
    Wang J; Mou X; Lu H; Jiang H; Xian Y; Wei X; Huang Z; Tang S; Cen H; Dong M; Liang Y; Shi G
    Front Endocrinol (Lausanne); 2023; 14():1302074. PubMed ID: 38327905
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Exploring conservative management for cervical intraepithelial neoplasia grade 2 in organised cervical cancer screening programmes: a multicentre study in Italy.
    Gori S; Frayle H; Pagan A; Soldà M; Romagnolo C; Insacco E; Laurino L; Matteucci M; Sordi G; Busato E; Zorzi M; Maggino T; Del Mistro A;
    Fam Med Community Health; 2024 Feb; 12(Suppl 2):. PubMed ID: 38307701
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Risk of cervical Abnormalities for Women With Multiple Sclerosis Treated With Moderate-Efficacy and High-Efficacy Disease-Modifying Therapies.
    Bridge F; Brotherton J; Stankovich J; Sanfilippo PG; Skibina OG; Buzzard K; Kalincik T; Nguyen AL; Guo K; Monif M; Wrede CD; Rath L; Taylor L; Butzkueven H; Jokubaitis VG; Van Der Walt A
    Neurology; 2024 Feb; 102(4):e208059. PubMed ID: 38306594
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Keeping your best options open with AI-based treatment planning in prostate and cervix brachytherapy.
    Dickhoff LRM; Scholman RJ; Barten DLJ; Kerkhof EM; Roorda JJ; Velema LA; Stalpers LJA; Pieters BR; Bosman PAN; Alderliesten T
    Brachytherapy; 2024; 23(2):188-198. PubMed ID: 38296658
    [TBL] [Abstract] [Full Text] [Related]  

  • 14.
    Zhang YT; Xu LJ; Li L
    Genet Test Mol Biomarkers; 2024 Jan; 28(1):10-21. PubMed ID: 38294357
    [No Abstract]    [Full Text] [Related]  

  • 15. [Expression of ProEXC and PRMT5 in cervical adenocarcinoma and their clinical significance].
    Cui HX; Lou XL; Xia W; Zhang YS; Cheng XY; Deng LF
    Zhonghua Yi Xue Za Zhi; 2023 Dec; 103(48):3967-3971. PubMed ID: 38129175
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Digital health interventions for cervical cancer care: A systematic review and future research opportunities.
    Razzak MA; Islam MN; Aadeeb MS; Tasnim T
    PLoS One; 2023; 18(12):e0296015. PubMed ID: 38100494
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Constructing a nomogram based on the distribution of thyroid nodules and suspicious lateral cervical lymph nodes in fine-needle aspiration biopsies to predict metastasis in papillary thyroid carcinoma.
    Liu SQ; Feng JW; Yan ZT; Xing XX; Jiang WY; Jiang Y; Qian F; Xing W
    Front Endocrinol (Lausanne); 2023; 14():1242061. PubMed ID: 38089614
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Conduction and validation of a novel prognostic signature in cervical cancer based on the necroptosis characteristic genes via integrating of multiomics data.
    Xu T; Jiang J; Xiang X; Jahanshahi H; Zhang Y; Chen X; Li L
    Comput Biol Med; 2024 Jan; 168():107656. PubMed ID: 38029530
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
    Zhao S; Li Y; Xu J; Shen L
    Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Matrine induces ferroptosis in cervical cancer through activation of piezo1 channel.
    Jin J; Fan Z; Long Y; Li Y; He Q; Yang Y; Zhong W; Lin D; Lian D; Wang X; Xiao J; Chen Y
    Phytomedicine; 2024 Jan; 122():155165. PubMed ID: 37922791
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 24.